- A new combined cell therapy for kidney transplants can reduce the donor-specific reaction against the transplanted organ without the need for maintenance triple immunosuppression.
- The therapy uses a combination of bone marrow cells from the donor and special immune cells (Treg cells) from the recipient.
- The therapy preserves the diversity of the T-cell receptor repertoire, which is crucial for immune defense.
- The study led by MedUni Vienna shows promising results in reducing the immune response to transplanted kidneys in humans.
- The research may lead to further studies and advancements in transplantation therapy.
Source link
Nephrology, Transplantation, Immunology